• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康保险公司是否具有创新性?来自医师薪酬结构的证据。

Do health insurers innovate? Evidence from the anatomy of physician payments.

机构信息

UCSD, USA; NBER, USA.

NBER, USA; UBC, Canada.

出版信息

J Health Econ. 2017 Sep;55:153-167. doi: 10.1016/j.jhealeco.2017.07.001. Epub 2017 Jul 13.

DOI:10.1016/j.jhealeco.2017.07.001
PMID:28784289
Abstract

One of private health insurers' main roles in the United States is to negotiate physician payment rates on their beneficiaries' behalf. We show that these rates are often set in reference to a government benchmark, and ask how often private insurers customize their fee schedules away from this default. We exploit changes in Medicare's payments and dramatic bunching in markups over Medicare's rates to address this question. Although Medicare's rates are influential, 25 percent of physician services in our data, representing 45 percent of covered spending, deviate from the benchmark. Heterogeneity in the pervasiveness and direction of deviations suggests that the private market coordinates around Medicare's pricing for simplicity but abandons it when sufficient value is at stake.

摘要

在美国,私人健康保险公司的主要角色之一是代表其受益人与医生协商支付费率。我们发现这些费率通常是参照政府基准设定的,那么私人保险公司会在多大程度上偏离这一基准来定制自己的收费表呢?我们利用医疗保险支付的变化和医疗保险费率的大幅溢价来解决这个问题。尽管医疗保险的费率具有影响力,但我们数据中有 25%的医生服务,占已覆盖支出的 45%,偏离了基准。偏差的普遍程度和方向的异质性表明,私人市场为了简单起见围绕着医疗保险的定价进行协调,但在涉及到足够的价值时,就会放弃它。

相似文献

1
Do health insurers innovate? Evidence from the anatomy of physician payments.健康保险公司是否具有创新性?来自医师薪酬结构的证据。
J Health Econ. 2017 Sep;55:153-167. doi: 10.1016/j.jhealeco.2017.07.001. Epub 2017 Jul 13.
2
Medicare's Bundled Payment Initiatives for Hospital-Initiated Episodes: Evidence and Evolution.医疗保险对医院发起的疾病诊治整体支付计划:证据与演变。
Milbank Q. 2020 Sep;98(3):908-974. doi: 10.1111/1468-0009.12465. Epub 2020 Aug 21.
3
Physician payment outlook for 2012: déjà vu.2012 年医生薪酬展望:似曾相识。
Pain Physician. 2012 Jan-Feb;15(1):E27-52.
4
Contrary to cost-shift theory, lower Medicare hospital payment rates for inpatient care lead to lower private payment rates.与成本转移理论相反,住院医疗服务中 Medicare 医院支付率的降低导致私人支付率的降低。
Health Aff (Millwood). 2013 May;32(5):935-43. doi: 10.1377/hlthaff.2012.0332.
5
In the Shadow of a Giant: Medicare's Influence on Private Physician Payments.在巨头的阴影下:医疗保险对私人医生薪酬的影响
J Polit Econ. 2017 Feb;125(1):1-39. doi: 10.1086/689772. Epub 2016 Dec 16.
6
Running Out of Reasons: Low Payments, Hassles Leave Physicians Wondering: Why stay in Medicare?理由殆尽:低报酬、诸多麻烦让医生们不禁思考:为何还要留在医疗保险计划中?
Tex Med. 2020 Jun 1;116(6):34-36.
7
Wide variation in hospital and physician payment rates evidence of provider market power.医院和医生支付费率存在广泛差异,这证明了供应商的市场力量。
Res Brief. 2010 Nov(16):1-11.
8
The repeal of Medicare's sustainable growth rate for physician payment.废除医疗保险对医生支付的可持续增长率。
JAMA. 2015 May 26;313(20):2025-6. doi: 10.1001/jama.2015.4550.
9
An analysis of methods to reform Medicare payment for physician services.改革医疗保险医师服务支付方式的方法分析。
Inquiry. 1987 Spring;24(1):36-47.
10
Caution advised: Medicare's physician-payment data release.建议谨慎对待:医疗保险医师支付数据发布。
N Engl J Med. 2014 Jul 10;371(2):101-3. doi: 10.1056/NEJMp1405322. Epub 2014 May 28.

引用本文的文献

1
Assessment of Phosphorodiamidate Morpholino Oligomer Treatment Patterns for Patients with Duchenne Muscular Dystrophy: A MarketScan Claims Analysis.杜氏肌营养不良症患者的磷酰二胺吗啉代寡聚物治疗模式评估:一项MarketScan索赔分析。
Adv Ther. 2025 Jan;42(1):523-536. doi: 10.1007/s12325-024-03044-z. Epub 2024 Nov 11.
2
Total knee arthroplasty reimbursement is declining overall and at a marginally faster rate amongst female orthopaedic surgeons: A Medicare analysis.全膝关节置换术的报销费用总体呈下降趋势,在女性骨科医生中下降速度略快:一项医疗保险分析。
J Orthop. 2024 Oct 19;63:8-15. doi: 10.1016/j.jor.2024.10.029. eCollection 2025 May.
3
Trading spaces: Medicare's regulatory spillovers on treatment setting for non-Medicare patients.
交易空间:医疗保险对非医疗保险患者治疗场所的监管溢出效应。
J Health Econ. 2022 Jul;84:102624. doi: 10.1016/j.jhealeco.2022.102624. Epub 2022 May 14.
4
Screening in Contract Design: Evidence from the ACA Health Insurance Exchanges.合同设计中的筛选:来自《平价医疗法案》医疗保险交易所的证据。
Am Econ J Econ Policy. 2019 May;11(2):64-107. doi: 10.1257/pol.20170014.
5
Discovering healthcare provider behavior patterns through the lens of Medicare excess charge.通过医疗保险超额收费的视角发现医疗服务提供者的行为模式。
BMC Health Serv Res. 2021 Jan 4;21(1):2. doi: 10.1186/s12913-020-05876-1.
6
THE PRICE AIN'T RIGHT? HOSPITAL PRICES AND HEALTH SPENDING ON THE PRIVATELY INSURED.价格不合理?医院价格与私人保险人群的医疗支出
Q J Econ. 2019 Feb;134(1):51-107. doi: 10.1093/qje/qjy020. Epub 2018 Sep 4.
7
Randomized trial shows healthcare payment reform has equal-sized spillover effects on patients not targeted by reform.随机试验表明,医疗保健支付改革对未被改革针对的患者产生了同等规模的溢出效应。
Proc Natl Acad Sci U S A. 2020 Aug 11;117(32):18939-18947. doi: 10.1073/pnas.2004759117. Epub 2020 Jul 27.
8
Do hospitals respond to changing incentive structures? Evidence from Medicare's 2007 DRG restructuring.医院是否会对不断变化的激励结构做出反应?来自 Medicare 2007 年 DRG 重组的证据。
J Health Econ. 2020 Sep;73:102319. doi: 10.1016/j.jhealeco.2020.102319. Epub 2020 May 18.
9
Health Care Spending and Utilization in Public and Private Medicare.公共及私人医疗保险中的医疗保健支出与利用情况
Am Econ J Appl Econ. 2019 Apr;11(2):302-332. doi: 10.1257/app.20170295.
10
Private provision of social insurance: drug-specific price elasticities and cost sharing in Medicare Part D.社会保险的私人供给:医疗保险D部分中特定药品的价格弹性与成本分担
Am Econ J Econ Policy. 2018 Aug;10(3):122-153. doi: 10.1257/pol.20160355.